Bayer | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Air Liquide EUR 1.92B 130M 2024-12
Akzo Nobel EUR 1.3B 656M 2024-12
Alcon AG USD 1.83B 112M 2024-12
Amarin USD 156.94M 58.98M 2024-09
Arkema EUR 2.01B 18M 2024-12
AstraZeneca USD 5.49B 691M 2024-12
BASF EUR 2.57B 343M 2024-09
Bayer EUR 6.19B 1.57B 2024-12
Beiersdorf EUR 1.21B 7M 2024-12
Corteva USD 3.11B 685M 2024-12
Covestro EUR 539M 30M 2024-09
Essilor EUR 2.25B 86M 2024-12
Fresenius EUR 2.28B 788M 2024-12
Fresenius Medical Care EUR 1.18B 191M 2024-12
Genmab DKK 9.86B 3.52B 2024-12
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.87B 678M 2024-12
GRIFOLS EUR 979.78M 334.84M 2024-12
Henkel EUR 1.85B 97M 2024-06
Hikma Pharmaceutical USD 0 1000K 2024-06
Johnson Matthey GBP 621M 79M 2024-09
Linde USD 4.85B 337M 2024-12
Lonza CHF 1.11B 286M 2024-12
Merck EUR 3.16B 476M 2024-09
Novartis USD 8.87B 4.74B 2024-12
Nutrien USD 853M 333M 2024-12
Philips EUR 2.4B 594M 2024-12
PPG Industries USD 1.27B 19M 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 6.8B 1.92B 2024-06
SAP EUR 9.61B 396M 2024-12
Solvay EUR 539M 17M 2024-12
UCB EUR 1.57B 1.14B 2024-12
Umicore EUR 2.01B 712.6M 2024-12
Vinci EUR 15.2B 2.5B 2024-12



Bayer Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.